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A B S T R A C T
Objectives
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:
To assess the eDectiveness of methods used during dental treatment procedures to minimise aerosol production and reduce or neutralise
contamination in aerosols.
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B A C K G R O U N D
The production of aerosols and splatter in dentistry is a major
health concern as aerosols generated during dental procedures are
contaminated with micro-organisms, which can lead to spread of
infection among dental professionals and their patients. The oral
cavity harbours over 700 species of bacteria and other infectious
microbes, which can be transmitted through aerosol-generating
procedures (AGPs) and cause respiratory health eDects or transmit
bidirectional diseases. As procedures in a dental clinic generally
involve close contact between patients and dentists, the risk
of infection in this setting can be high (Meng 2020), though
some studies have found no increased prevalance of respiratory
infections among dentists (Scannapieco 2004).
The World Health Organization (WHO) has previously reported
disease outbreaks of Ebola virus, Middle East respiratory syndrome
(MERS-CoV), severe acute respiratory syndrome (SARS-CoV), swine
flu, avian influenza (H5N1 flu), tuberculosis and measles across the
world, and we are currently experiencing the COVID-19 pandemic
(WHO 2020). Based on risk assessment, WHO has recommended
airborne precautions for settings in which AGPs and support
treatment are performed (WHO 2020a), thus leading several
countries to temporarily suspend all elective dental procedures.
Dental professional organisations have proposed infection control
protocols (ADA 2020; ALOP 2020; BDA 2020a; CDC 2020; Dominiak
2020; NCUDSPH 2020), and recommendations to postpone elective
procedures, surgeries and non-urgent dental visits (ADA 2020;
CDC 2020; NCUDSPH 2020). This rapid review aims to explore the
evidence on the eDectiveness of various methods that can be
used to reduce contaminated aerosols generated during dental
procedures.
Description of the condition
Dental professionals have an important role in preventing the
transmission of any infection. The possible routes for the spread
of most viral, bacterial and fungal infections in a dental clinic are
droplet, contact and airborne (Peng 2020). These routes can be
bidirectional, meaning transmission may occur from patient-to-
patient, patient-to-clinician or clinician-to-patient (Laheij 2012). It
is unclear how much each form of transmission contributes to the
risk of infection, but it is assumed that airborne transmission occurs
only when a large volume of aerosol particles are generated (Harrel
2004).
The incubation period of common bacterial and viral infections
ranges between two and 14 days during which the patient is
asymptomatic but the chance of contamination and spread may
still exist (Lessler 2009). The incubation period of the current
pandemic due to COVID-19 has been estimated at five to six days
on average, but it could be as long as 14 days (Meng 2020). The
incubation period of SARS virus infection was reported to be 10
days, though with a low risk of transmission in the prodromal
phase (Samaranayake 2004). This uncertainty makes it prudent to
consider all patients to be potential sources of infection.
Transmission of infection in the dental clinic primarily occurs
by direct contact with the respiratory droplets from the infected
person, or indirect contact with surfaces in the immediate
environment or with objects used on the infected person that
generate larger amounts of contaminated aerosols (e.g. dental
chair or dental instruments) (Upendran 2020). Aerosol scientists
and other researchers are debating whether COVID-19 spreads
via air and AGPs (Lewis 2020). Leung 2020 detected rhinovirus,
influenza and human coronaviruses (excluding SARS-CoV-2) in
respiratory droplets and aerosols. WHO states that airborne
transmission may be possible during certain medical procedures
such as bronchoscopy (WHO 2020a).
Di2erentiation of aerosols
Aerosols are diDerentiated based on particle size: splatter when
they are greater than 50 µm; droplets when 11 µm to 50 µm; droplet
nuclei when 10 µm or less. Most of the aerosols produced in the
dental settings are extremely small (less than 5 µm) (Harrel 2004;
James 2016), vary in size depending on the procedures (Polednik
2014), and submicrometre particles have been demonstrated in
various dental procedures in laboratory settings (Polednik 2014;
Sotiriou 2008).
Splatter, being the larger particles, are airborne only briefly. They
fall to the ground or settle on surfaces in the dental operatory
(Harrel 2004). Droplets remain suspended in the air until they
evaporate, leaving droplet nuclei that may contain bacteria related
to respiratory infections. Droplet nuclei can contaminate surfaces
to a range of three feet and may remain airborne for 30 minutes to
two hours. If inhaled, the droplet nuclei can penetrate deep into the
respiratory system (Harrel 2004; James 2016; Kormuth 2018).
What is the composition of contaminated droplets or aerosols?
The oral cavity is a nidus for several bacteria and viruses. It
also harbours bacteria and viruses from the nose, throat and
respiratory tract. Hence, diDerent strains of micro-organisms and
viruses are present in aerosols generated when dental AGPs are
carried out, making them contaminated aerosols or bio-aerosols
or microbial aerosols (Zemouri 2017). Apart from micro-organisms,
components of saliva, nasopharyngeal secretions, plaque, blood,
tooth components and any material used in the dental procedures
such as abrasives for air polishing and air abrasion, are commonly
present in dental aerosols. While multiple studies have been
conducted to determine which dental procedure produces the
most airborne bacterial contamination (Jain 2020; Monarca 2000;
Polednik 2014; Rautemaa 2006); viral particles such as influenza,
rhinoviruses, SARS coronavirus and bacteriae such as Mycobacteria
tuberculi and strict anaerobic bacteria could not be measured in
these studies as the culture medium used was not suitable (Harrel
2004).
What are the sources of aerosols and splatter in dental
workplace?
A four-fold increase of airborne bacteria has been observed in
areas where dental aerosol-producing equipment is used (Sawhney
2015). According to General Dental Council in the UK, dental
AGPs include use of high-speed handpieces for routine restorative
procedures, use of ultrasonic scalers and high pressure 3:1 air
syringe, polishing teeth, use of air-driven surgical handpieces, air
abrasion, slow speed polishing and opening teeth for drainage
(FGDP 2020; GDC 2020). In addition, some non-AGPs such as
intraoral radiography can evoke gag reflex leading to coughing
or sneezing that results in aerosols. The British Association of
Oral Surgeons and British Association of Oral and Maxillofacial
Surgeons advises that all urgent dental procedures, including oral
examination, be treated as aerosol-generating (FGDP 2020).Dental
hand pieces, ultrasonic scalers, air polishers and air abrasion
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units produce the most visible aerosols. Each of these instruments
removes material from the operative site thus generating aerosols
by the action of rotary instruments, ultrasonic vibrations, or the
combined action of water sprays and compressed air. Using the
bacterial growth method, the ultrasonic scaler has been shown to
produce the greatest amount of airborne contamination, followed
by the air-driven high-speed handpiece, the air polisher and other
instruments such as the air-water syringe and prophylaxis angles
(Barnes 1998; Gross 1992; Harrel 1996; Harrel 2004; Muzzin 1999).
The particle size of these dental aerosols is less than 50 μm and their
small size means they tend to be suspended in the air for longer
period of time (Cottone 1991).
One in-vitro study reported that the position of the handpiece in the
dental arch influences the amount of splatter. When the water spray
is positioned closer to the oral aperture (e.g. near upper anterior
teeth), it is more likely that there is escape of water from the mouth
rather than adhering to adjacent oral surfaces or the rubber dam
(Dahlke 2012).
Description of the intervention
Harrel 2004 suggested layering infection control steps to reduce
the potential danger from contaminated dental aerosols, which
consisted of: 1. barrier protection – mask, gloves and eye
protection; 2. preprocedural rinse with antiseptic mouthwash; 3.
high volume evacuator; 4. high eDiciency particulate air room filters
and ultraviolet (UV) treatment of ventilation system. Many other
techniques and devices have been introduced since the early 2000s.
We have devised an infographic based on Harrel 2004 to categorise
interventions used to reduce contaminated aerosols produced
during dental procedures (Figure 1).
 
Figure 1.
 
Interventions that are not included in our reviews• Personal protective equipment (PPE)
PPE includes aprons, gowns or coveralls (a one-piece suit),
gloves, masks, breathing equipment (respirators) and goggles. PPE
reduces operator (dentist, dental assistant or dental laboratory
personnel) contact of aerosols thus protecting from exposure to
microbial organisms in the aerosol. A Cochrane Review on this topic
has recently been published (Verbeek 2020).
• Preprocedural mouth rinses
Preprocedural mouth rinses (e.g. chlorhexidine, povidone-iodine
and hydrogen peroxide) have antimicrobial action; they help
reduce the salivary concentration of microbial organisms thereby
reducing the number of viable microbial organisms in the aerosols
during AGPs (Eggers 2018; Harrel 2004). A limitation of the studies
testing eDectiveness of aerosol-reducing interventions is the use of
bacterial colony-forming units (CFU) as a surrogate measurement
tool to check for reduction in contaminated aerosol. Hence, in
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patients where the preprocedural rinses are used, the true eDicacy
of the other interventions may be obscured as the bacterial count
in the saliva itself is controlled. Use of mouth rinses in the context of
Covid-19 specifically is currently being evaluated in rapid reviews
being undertaken jointly by Cochrane Oral Health and Cochrane Ear
Nose and Throat (Burton 2020a; Burton 2020b). Once we complete
the current review, we hope to undertake a review of preprocedural
mouth rinses for prevention of any infectious disease.
Interventions included in this review• Interventions that prevent contamination of aerosols in the
mouth (Harrel 2004)* Anti-microbial agents such as chlorhexidine and povidine
iodine are used as coolants along with ultrasonic scalers to
reduce the contamination of aerosols in the mouth (Sethi
2019).• Interventions that prevent contaminated aerosols from
escaping the mouth (Harrel 2004)* Use of a rubber dam during AGPs prevents patient saliva
being mixed with the water spray generated from the drill or
scaler.* Saliva ejectors (low volume evacuators or low volume
aspirators) reduce the aerosols escaping the mouth.• Interventions that prevent contaminated aerosols from
escaping the immediate operating site (local ventilation)* Aerosols coming out of the mouth can be removed with local
exhaust ventilation such as high-volume evacuation systems
(HVE).• Interventions that reduce overall concentration of aerosols
in dental operatory (general ventilation)* Once the contaminated aerosols escape the immediate
operating site and become airborne, air purification methods
can be used to tackle them, such as high eDiciency
particulate air (HEPA) filters, which aim at reducing the
overall concentration of aerosols in the dental operatory
(Harrel 2004; Yadav 2015).* Ionisation makes the aerosol particles unipolarly charged
and thus they repel each other to deposit on the surfaces
(Yadav 2015).* Other methods such as avoiding the use of fans that can
recirculate the air (Warnakulasuriya 2020), keeping windows
open in the dental operatory room and using exhaust fans
(Escombe 2019; Stockwell 2019) have been suggested.• Interventions that decontaminate aerosols in the air* UV light (Yadav 2015): UV has germicidal properties and short
wavelength UV-C (250 nm to 265 nm wavelength) is used for
disinfection purposes.* Ozonisation (Yadav 2015): ozone, an allotrope of oxygen,
owes its antimicrobial activity to its high oxidative potential.* Fumigation (Bali 2014) and fogging (McDonnell 2006):
fumigation is a chemical method of decontaminating the air
in an operating theatre or a clinic by spraying formaldehyde
and potassium permanganate in liquid form; fogging uses
a mixture of hydrogen peroxide and silver ion solution in
the form of aerosols to control the contaminated aerosols
(McDonnell 2006).• Combination of methods; other methods
Dentists can select diDerent combinations of the above methods;
for example, Cochran 1989 evaluated rubber dam together with
HVE and Narayana 2016 assessed preprocedural rinse and HVE
to reduce contamination in aerosols. Modifications of existing
techniques or equipment may be used, or new devices, e.g. Isolite
illuminated dental isolation system (Zyris 2020).
How the intervention might work
Interventions that prevent contamination of aerosols in the
mouth
Anti-microbial agents such as chlorhexidine gluconate and
povidine iodine are used as ultrasonic coolants to prevent the
contamination of aerosols in the mouth and biofilm formation
(Sethi 2019). These agents are used in solution form and lesser
concentrations than the agents used in preprocedural rinse or
local irrigation. This reduces the contamination of the waterlines,
penetration of the agent into the periodontal pocket increases and
thus acts on the local microbia to prevent the contamination of
aerosols produced (Jawade 2016).
Interventions that prevent contaminated aerosols from
escaping the mouth
1. Rubber dam
The rubber dam is a disposable rubber sheet that is stretched
around the treated tooth or teeth, and works by isolating the
treatment zone from saliva (Al-amad 2017). Two studies observed
a significant reduction in bacterial atmospheric contamination
when rubber dams were used (Cochran 1989; Samaranayake
1989). However, contradictory results are reported by Al-amad
and colleagues, which showed an increase in the bacterial
contamination on the headscarf of the students who used a rubber
dam (Al-amad 2017). Rubber dam application in certain situations
may not establish a perfect seal around the tooth and even expose
the gingiva due to reduced clinical crown height (when not using
the split dam technique). This can lead to leakage of contaminated
saliva, which results in aerosols and thus reduces the eDiciency
of rubber dam isolation (Al-amad 2017; Cochran 1989; Fors 1986).
Rubber dam may not be of much use in prevention of contaminated
aerosols when AGPs are performed on a carious tooth which
not only harbours the caries-causing microbial flora, but other
microbial organisms including fungi and viruses.
2. Saliva ejectors
A saliva ejector is a narrow, tubular device that provides suction
to remove saliva, blood, tooth material and debris from the mouth
during the dental procedures to provide a clear operating field
(Merriam-Webster 2020). The use of saliva ejectors with low or
high volume was shown to reduce the production of droplets and
aerosols in one study (Yadav 2015); however, neither saliva ejectors
nor HVE devices reduced the aerosols and splatter eDectively in
another study (Holloman 2015). Saliva ejectors in conjunction with
HVE devices are more eDective than saliva ejectors used alone
(Graetz 2014). This is because of the smaller diameter of the
tip, which is not capable of clearing the aerosols. Saliva ejectors
are preferred in dental practices because of their usefulness in
providing a clear operating field, convenient use and comfort as
opposed to HVE devices (Graetz 2014; Jacks 2002).
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Local ventilation (interventions that prevent contaminated
aerosols from escaping the immediate operating site)
1. High volume suction evacuation (high volume evacuator
devices or high volume aspirators)
HVE devices are suction devices fitted on an evacuation system
that can draw a large volume of air within a short period of time
(Avasthi 2018; Harrel 2004). The usual HVE device used in dentistry
has a large opening (usually 8 mm or greater) and is attached to
an evacuation system that will remove up to 2.8 cubic metres of
air per minute (Harrel 2004). They have been tested in controlling
aerosol production in dental settings and studies have shown
varying results, with 90.8% reduction of aerosols (Jacks 2002) to
no statistically significant diDerence between using and not using
HVE devices (Desarda 2014). Proper distance should be maintained
by clinicians while holding HVE devices. The device should be held
approximately 6 mm to 15 mm away from the active ultrasonic tip
or air polisher (Avasthi 2018).
General ventilation
1. High eiciency particulate air filters
A HEPA filter is composed of a mat of randomly arranged fibres and
can remove 99.95% (European Standard) of particles measuring
0.3 μm in diameter, from the air that passes through (European
Standard 2009 – EN 1822-1:2009). In the USA, the Institute of
Environmental Sciences and Technology (IEST) requires a certified
HEPA filter to capture a minimum of 99.97% of contaminants 0.3
mm in size and larger, which means that for every 10,000 particles
that pass through the filter, only three can be permitted to escape
(Yadav 2015). Filtration involves physical removal of particulates
from the air and is a vital aspect in achieving acceptable indoor
air quality. Air purifiers utilise diDerent types of filtration such as
carbon, HEPA or a mixture such as a carbon/HEPA filtration unit.
While a carbon filter is ideal for chemicals and odours in the air,
HEPA is ideal for air particles. According to IEST, there are six types
of filters used in HEPA (type A, B, C, D, E and F), dependent on
performance (Veeck 2004). Portable HEPA filters are also available
and are eDective in particle reduction when tested in simulated
hospital wards (Qian 2010).
2. Ionisation
Ionisers or ionic air purifiers are devices that can either be wearable
or stationary. They use charged electrodes to project negative ions
into the air. These devices impart electrical charges of the same
polarity on aerosol particles. These unipolarly charged particles
then repel each other and move away from breathing zone to
be deposited on the nearby surfaces (Grinshpun 2001). Another
possible mechanism for how this works is that the micro-organisms
floating in the air attract these negatively charged ions and become
heavier as a result and then precipitate onto surfaces. However,
the micro-organisms are not destroyed through this process. They
remain viable and thus require further treatment through some
more conventional form of disinfection (Yadav 2015).
3. Other methods
Other methods, such as avoiding the use of fans, keeping windows
open at the dental operatory room and using exhaust fans may
help by improving the air circulation (Escombe 2019; Meng 2020;
Stockwell 2019).
Decontamination of aerosols in the air
1. Ultraviolet light
Air sterilisation is done using IV irradiation. The DNA of all bacteria
and viruses are ruptured, thus rendering them sterile and incapable
of reproduction (Harrel 2004; Yadav 2015).
2. Ozonisation
Ozone attacks the cell membrane of bacteria, possible through
ozonolysis of carbon–carbon double bonds of membrane lipids
leading to lysis of the cell (Gurley 1985). Laboratory studies have
shown that ozone at a concentration of over 100 ppm with high
humidity was highly virucidal against ribonucleic acid (RNA) viruses
(Sato 1990). Ozone molecules are highly reactive and, when they
come into contact with micro-organisms, they react, rendering
them harmless. Concerns have been raised about the amount
of ozone required to destroy pathogens in the air and whether
that would present a health risk to dental personnel and patients
(Yadav 2015); however, the half-life of ozone is 20 minutes and it
decomposes to oxygen thus not posing a health hazard (Brown
1999).
3. Fumigation and fogging
Fumigation with formaldehyde was able to reduce Staphylococcus
aureus, Streptococcus spp, Escherichia coli and Aspergillus spp in
samples obtained in a maxillofacial operating theatre in India
because of its bactericidal properties (Bali 2014).
Nowadays, this fumigation method is seldom used because of
the carcinogenic eDect of formaldehyde and instead, fogging is
preferred. Fogging uses a mixture of hydrogen peroxide and silver
ion solution to control the contaminated aerosols through its
bactericidal action (McDonnell 2006).
Why it is important to do this review
The recent COVID-19 pandemic and similar communicable diseases
have always posed a high risk to health professionals (Coulthard
2020; Laheij 2012; Peng 2020; Samaranayake 2004; Scannapieco
1999). AGPs such as dental drills and surgical drills used in oral
surgery procedures form aerosols contaminated with bacteria,
fungi and viruses (Al-Eid 2018; Ishihama 2008; Szymańska 2007).
Dentists who treat patients using such AGPs are at risk of
contaminating and inoculating themselves if the patient is
infected with infections such as COVID-19 and SARS (Peng 2020;
Samaranayake 2004). Dental assistants, other oDice staD members,
and patients are also at risk of inoculation (Froum 2020). According
to the US Department of Labor, dental hygienists, dental assistants
and general dentists have the highest occupational risk for
COVID-19 with a risk score of 99.7% (hygienists), 92.5% (assistant)
and 92.1% (general dentist) (Lu 2020). Similarly, the Occupational
Safety and Health Act (OSHA), categorises occupations involved
with aerosol production as very high risk (OSHA 2020). The first
report on a dentist and two dental nurses contracting COVID-19
infection was outlined by Wuhan Dental Hospital in the early weeks
of the pandemic (Meng 2020).
Dental professionals in many countries have stopped routine
care because of regulatory restrictions and fear of spreading
COVID-19 among their patents and beyond. This closure brings
significant financial impact for dental professionals, especially for
self-employed practitioners (Coulthard 2020) or dental practices
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with an NHS contract (UK) who have furloughed their staD. The
Association of British Insurers have warned majority of the dental
clinics in the UK are not covered for business interruption claims
due to the COVID-19 pandemic (BDA 2020b). Moreover, the abrupt
closure of dental services has leQ many patients midway through
procedures such as root canal treatment, dentures, orthodontic
treatment, fixed partial dentures and implant-supported dentures.
Patients may be in pain but in fear of attending for urgent treatment
or delayed treatment may exacerbate non-urgent problems. This
review will help dental professionals prepare themselves to
adopt best practices during and aQer the COVID-19 pandemic,
by identifying the best methods for reduction of contaminated
aerosols in their dental clinics and thus reduce the risk of infectious
diseases spreading through aerosols.
O B J E C T I V E S
To assess the eDectiveness of methods used during dental
treatment procedures to minimise aerosol production and reduce
or neutralise contamination in aerosols.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomised controlled trials (RCTs) and controlled
clinical trials (CCTs) conducted in a dental environment. We
will include studies where the unit of randomisation is dental
professionals, participants, dental units or practices.
We will exclude experimental studies conducted in a laboratory
environment.
Types of participants
We will include studies with dental staD (dentist, dental surgery
assistant, dental hygienist, dental technologist, dental laboratory
staD or dental aide) and their patients undergoing a dental AGP.
Types of interventions
We will include any method, procedure or policy that aims to reduce
contaminated aerosols in dental clinics compared to any other
method or combination of methods.
We will categorise the interventions as:
• methods to prevent contamination of aerosols in the mouth -
antimicrobial coolants;• methods to prevent contaminated aerosols escaping from the
mouth;• local ventilation;• general ventilation;• decontamination of aerosols in the air;• combination of methods.
Types of outcome measures
As this is a rapid review, we are considering only the following key
outcomes.
Primary outcomes• Incidence of infection of dental staD or patients.
• Reduction in volume of contaminated aerosols in the operative
environment.
The reduction of these aerosols can be measured directly as a
decrease in the amount of particles, using optical particle counters,
condensation nuclei counters, aerodynamic analyses, scanning
mobility particle sizer spectrometers (Górny 2020), adenosine
triphosphate (ATP) bioluminescence (Watanabe 2018), or use of
fluorescent dye to count splatter (Veena 2015).
• Reduction in level of contamination in aerosols in the operative
environment.
The reduction in contamination can be measured with surrogate
methods such as bacterial CFU of oral bacteria that are found
in the working environment or standard index of microbial air
contamination (IMA) (Pasquarella 2000). We call this a surrogate
outcome because these bacterial CFUs do not represent the
quantity of aerosols. The CFUs can be the result of any
contamination and not just from aerosols, thus making it a less
reliable outcome measure.
Secondary outcomes• Costs for the interventions used (measured in local currency).• Acceptability and feasibility of the intervention to patients
and dentists (measured using ordinal (e.g. Likert scale) or
dichotomous (e.g. yes/no) data).
Search methods for identification of studies
Cochrane Oral Health's Information Specialist will conduct
systematic searches for RCTs and CCTs. There will be no language,
publication year or publication status restrictions. We will contact
original authors for clarification and further data if trial reports are
unclear and we will arrange translations of papers where possible.
Electronic searches
Cochrane Oral Health's information specialist will search the
following databases from their inception:
• Cochrane Oral Health's Trials Register;• the Cochrane Central Register of Controlled Trials (CENTRAL) in
the Cochrane Register of Studies;• MEDLINE Ovid (from 1946 onwards);• Embase Ovid (from 1980 onwards);• WHO COVID-19 Global literature on coronavirus disease
(search.bvsalud.org/global-literature-on-novel-
coronavirus-2019-ncov; search to date)
Subject strategies will be modelled on the search strategy designed
for MEDLINE Ovid. Where appropriate, they will be combined
with subject strategy adaptations of the highly sensitive search
strategies designed by Cochrane for identifying RCTs and CCTs
as described in the Cochrane Handbook for Systematic Reviews of
Interventions, Technical Supplement to Chapter 4 (Lefebvre 2019).
Searching other resources
Cochrane Oral Health's information specialist will search the
following databases to identify ongoing studies:
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (clinicaltrials.gov/);
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• Cochrane COVID-19 Study Register (covid-19.cochrane.org/)
(search via the Cochrane Register of Studies).
A search of the WHO's International Clinical Trials Registry Platform
is mandatory for Cochrane Reviews; however, this database will
not be available at the time of the search due to the COVID-19
pandemic. We will search this database for any updates of this
review.
We will also undertake a non-systematic search of the internet
using Google.
We will not perform a separate search for adverse eDects. We will
consider adverse eDects described in included studies only.
We will make eDorts to identify full-text papers regardless
of language of publication and endeavour to seek help with
translation; however, we will not delay the rapid review process.
Any papers that we are unable to source quickly or are unable to get
translated will be listed as awaiting assessment.
Data collection and analysis
Selection of studies
Two review authors will screen at least 20% (search results) of the
titles and abstracts for calibration purposes. We will consider a
minimum of 80% agreement between these two review authors.
AQer calibration, one review author will screen the abstracts
and the second review author will screen all excluded abstracts.
Any conflicts during the screening will be resolved by mutual
discussion. If this is not possible, a third review author (arbiter) will
be consulted and consensus will be reached through discussion. We
will use online Rayyan soQware to screen the titles and abstracts
(Rayyan 2016).
Two review authors will screen at least 20% of full-text articles
for calibration purposes. We will consider a minimum of 80%
agreement between these two review authors. Then, one review
author will screen all the full-text articles with a second review
author to screen all excluded full-text articles and complete a
'Characteristics of excluded studies' table. For included studies, we
will extract useful information and data from the full-text articles
and complete a 'Characteristics of included studies' table.
Where studies have multiple publications, we will collate the
reports of the same study so that each study, rather than each
report, is the unit of interest for the review, and such studies have a
single identifier with multiple references.
Data extraction and management
One review author will design the data extraction form and one
review author will test its suitability. One review author will extract
the data using the data extraction form. The second review author
will verify the correctness and completeness of data extracted. We
will limit data extraction to a minimal set of required data items.
Assessment of risk of bias in included studies
Two review authors will assess risk of bias, using the Cochrane
'Risk of bias' tool for RCTs and ROBINS-I tool for CCTs, and report
the results in a table (Higgins 2019). For RCTs, we will classify
each domain at high, low or unclear risk of bias (Higgins 2019).
For CCTs, we will classify each domain at low, moderate, serious,
critical risk of bias or no information to assess risk of bias (Sterne
2016). We will attempt to contact the trial authors if information
is not specified or is unclear. We will resolve any disagreements
by discussion between the review authors. If consensus cannot be
reached, we will consult a third review author (arbiter). Preferably,
we want to include studies that randomise staD to intervention
and control with a suDiciently large sample of patients. If patients
are randomised but the same professional is implementing both
interventions being compared, there is a higher likelihood of
performance bias.
Measures of treatment e2ect
We will present the eDect sizes for dichotomous outcomes as
risk ratios (RR) and 95% confidence intervals (CIs). We will report
continuous outcomes as mean diDerences (MD) and 95% CIs. If the
included trials have reported continuous outcomes obtained from
diDerent instruments, we will use the standardised mean diDerence
(SMDs) and 95% CI as the eDect measure. We will qualitatively
describe the costs for the interventions used. If we find ordinal data,
we will dichotomise the data and present the eDect sizes as RR and
95% CIs.
Unit of analysis issues
We do not anticipate that any cluster-randomised studies will meet
the inclusion criteria of this review. If we identify multi-arm trials,
we will select relevant arms for inclusion in our analyses. If more
than two arms are relevant to this review, we will split the control
group between multiple comparisons so that participants are not
double-counted in meta-analysis.
Dealing with missing data
If we encounter trials with missing data, we will contact the
investigators or sponsors of these studies, wherever possible. We
will calculate missing data from other data such as standard
deviations (SDs) from P values if needed. We will re-analyse the
data according to the intention-to-treat (ITT) principle whenever
possible.
Assessment of heterogeneity
We will assess heterogeneity by visually inspecting the forest
plots to determine closeness of point estimates with each other
and overlap of CIs. We will use the Chi2 test with a P value
of 0.1 to indicate statistical significance. We will also use the
I2 statistic, following the interpretation recommended in the
Cochrane Handbook for Systematic Reviews of Interventions (0%
to 40% might not be important; 30% to 60% may represent
moderate heterogeneity; 50% to 90% may represent substantial
heterogeneity; 75% to 100% considerable heterogeneity).
Assessment of reporting biases
If we include 10 or more studies, we will construct a funnel plot to
investigate any potential reporting bias.
Data synthesis
We will analyse the data using Review Manager 5 (Review Manager
2014). In the absence of substantial clinical or methodological
heterogeneity, we will perform a meta-analysis using a random-
eDects model. If there is substantial or considerable heterogeneity,
we will investigate heterogeneity using a subgroup analysis. Where
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a meta-analysis is not appropriate, we will discuss the data
narratively.
Subgroup analysis and investigation of heterogeneity
We plan to investigate heterogeneity by performing the following
subgroup analyses.
• Type of AGP (e.g. ultrasonic and sonic scaling, tooth preparation
using air turbine handpiece or air abrasion, three-way syringe).• Type of clinical set-up (e.g. single chair, polyclinic, operating
theatre for minor oral surgery).• Types of filters used in HEPA (e.g. type A, B, C, D, E or F).• Procedure performed in anterior teeth or posterior teeth.• Biological assessment used (CFU, fluorescent dye-stained
splatter).• Position of the culture plates (for CFU).
Sensitivity analysis
To explore the possible eDect of losses to follow-up on the eDect
estimates for the primary outcomes, we will perform sensitivity
analyses. For dichotomous outcomes, we will vary the event rate
within the missing participants from intervention and control
groups within plausible limits. We will perform sensitivity analyses
for assumptions that we have made in our analyses. We will remove
those studies at high risk of bias or NRCTs (or both) and report any
significant diDerence between the results of these analyses.
Summary of findings and assessment of the certainty of the
evidence
We will summarise the results of the analyses in 'Summary of
findings' tables for the primary outcomes for all comparisons.
• Incidence of infection of dental staD or patients.• Reduction in volume of contaminated aerosols in the operative
environment.• Reduction in level of contamination in aerosols in the operative
environment.
We will use the GRADE framework to evaluate the certainty of
evidence for each outcome as high, moderate, low or very low,
as described in the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2019). We will justify all decisions to
downgrade the certainty of the evidence using footnotes and we
will make comments to aid reader's understanding of the review
where necessary.
A C K N O W L E D G E M E N T S
We are extremely thankful to Cochrane Oral Health: Anne
Littlewood, Information Specialist; Laura MacDonald, Managing
Editor; Professor Anne Marie Glenny and Professor Jan Clarkson,
Co-ordinating Editors; and Professor Helen Worthington. We
thank peer reviewers Professor Nicola Innes, Derek Richards and
Professor Julián Balanta Melo, and copy editor Anne Lawson.
We thank Professor Dr Jaspal Singh Sahota, Chief Executive,
Melaka-Manipal Medical College, Melaka campus and Professor Dr
Abdul Rashid Hj Ismail, Dean, Faculty of Dentistry, Melaka-Manipal
Medical College for constant support to undertake Cochrane
Reviews.
We would like to thank Farhad Shokraneh, Information Specialist
at Cochrane Schizophrenia, University of Nottingham, for peer
reviewing the search strategy and Dr Tony Francis, Assistant
Professor in Department of Conservative and Endodontics, Faculty
of Dentistry, Melaka-Manipal Medical College for the valuable input
during the preparation of this protocol.
Interventions to reduce contaminated aerosols produced during dental procedures for preventing infectious diseases (Protocol)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
8
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
R E F E R E N C E S
 
Additional references
ADA 2020
American Dental Association. COVID-19 frequently
asked questions. success.ada.org/en/practice-
management/patients/coronavirus-frequently-asked-
questions?utm_source=cpsorg&utm_medium=covid-
nav&utm_content=nav-faq&utm_campaign=covid-19 (accessed
16 April 2020).
Al-amad 2017
Al-amad SH, Awad MA, Edher FM, Shahramian K, Omran TA. The
eDect of rubber dam on atmospheric bacterial aerosols during
restorative dentistry. Journal of Infection and Public Health
2017;10(2):195-200.
Al-Eid 2018
Al-Eid RA, Ramalingam S, Sundar C, Aldawsari M, Nooh N.
Detection of visually imperceptible blood contamination in the
oral surgical clinic using forensic luminol blood detection agent.
Journal of International Society of Preventive & Community
Dentistry 2018;8(4):327-32. [PMID: 30123765]
ALOP 2020
The Latin American Association of Pediatric Dentistry
(Asociación Latinoamericana de Odontopediatría ALOP).
Recommendations for care in pediatric dentistry versus
Covid-19. www.acop.com.co/2020/04/13/recomendaciones-de-
atencion-en-odontopediatria-frente-al-covid-19/ (accessed 13
April 2020).
Avasthi 2018
Avasthi A. High volume evacuator (HVE) in reducing aerosol – an
exploration worth by clinicians. Journal of Dental Health, Oral
Disorders & Therapy 2018;9(3):165-6.
Bali 2014
Bali R, Sharma P, Nagrath S, Gupta P. Microbial isolations from
maxillofacial operation theatre and its correlation to fumigation
in a teaching hospital in India. Journal of Maxillofacial and Oral
Surgery 2014;13(2):128-32. [PMID: 24822003]
Barnes 1998
Barnes JB, Harrel SK, Rivera-Hidalgo F. Blood contamination
of the aerosols produced by in vivo use of ultrasonic scalers.
Journal of Periodontology 1998;69(4):434-8.
BDA 2020a
British Dental Association. Personal protective equipment
(PPE). bda.org/advice/Coronavirus/Pages/face-mask-
shortage.aspx (accessed 6 June 2020).
BDA 2020b
British Dental Association. Coronavirus: the financial impact.
bda.org/advice/Coronavirus/Pages/financial-impact.aspx
(accessed 6 June 2020).
Brown 1999
Brown K, Xu Y. Fogging for the disinfection of food processing
factories and equipment. Trends in Food Science & Technology
1999;10(6-7):205-10.
Burton 2020a
Burton MJ, Clarkson JE, Goulao B, Glenny A-M, McBain AJ,
Schilder AG, et al. Antimicrobial mouthwashes (gargling) and
nasal sprays to protect healthcare workers when undertaking
aerosol-generating procedures (AGPs) on patients without
suspected or confirmed COVID-19 infection. Cochrane Database
of Systematic Reviews 2020, Issue 5. Art. No: CD013628. [DOI:
10.1002/14651858.CD013628]
Burton 2020b
Burton MJ, Clarkson JE, Goulao B, Glenny A-M, McBain AJ,
Schilder AG, et al. Use of antimicrobial mouthwashes (gargling)
and nasal sprays by healthcare workers to protect them when
treating patients with suspected or confirmed COVID-19
infection. Cochrane Database of Systematic Reviews 2020, Issue
5. Art. No: CD013626. [DOI: 10.1002/14651858.CD013626]
CDC 2020
Centers for Disease Control and Prevention. Dental settings:
interim infection prevention and control guidance for dental
settings during the COVID-19 response. www.cdc.gov/
coronavirus/2019-ncov/hcp/dental-settings.html (accessed 27
April 2020).
Cochran 1989
Cochran MA, Miller CH, Sheldrake MA. The eDicacy of the rubber
dam as a barrier to the spread of microorganisms during
dental treatment. Journal of American Dental Association
1989;119(1):141-4.
Cottone 1991
Cottone JA, Terezhalmy GT, Molinari JA. Practical Infection
Control in Dentistry. Baltimore (MD): Williams and Wilkins, 1991.
Coulthard 2020
Coulthard P. Dentistry and coronavirus (COVID-19) – moral
decision-making. British Dental Journal 2020;228(7):503-5.
Dahlke 2012
Dahlke WO, Cottam MR, Herring MC, Leavitt JM, Ditmyer MM,
Walker RS. Evaluation of the spatter-reduction eDectiveness of
two dry-field isolation techniques. Journal of American Dental
Association 2012;143:1199-204.
Desarda 2014
Desarda H, Gurav A, Dharmadhikari C, Shete A, Gaikwad S.
EDicacy of high-volume evacuator in aerosol reduction: truth
or myth? A clinical and microbiological study. Journal of Dental
Research, Dental Clinics, Dental Prospects 2014;8(3):176-9.
Dominiak 2020
Dominiak M, Różyło-Kalinowska I, Gedrange T, Konopka T,
Hadzik J, Bednarz W, et al. COVID-19 and professional dental
practice. The Polish Dental Association Working Group
Interventions to reduce contaminated aerosols produced during dental procedures for preventing infectious diseases (Protocol)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
9
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
recommendations for procedures in dental oDice during
an increased epidemiological risk. Journal of Stomatology
2020;73(1):1-10.
Eggers 2018
Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. In vitro
bactericidal and virucidal eDicacy of povidone-iodine gargle/
mouthwash against respiratory and oral tract pathogens.
Infectious Diseases and Therapy 2018;7(2):249-59.
Escombe 2019
Escombe AR, Ticona E, Chávez-Pérez V, Espinoza M, Moore DA.
Improving natural ventilation in hospital waiting and consulting
rooms to reduce nosocomial tuberculosis transmission risk in
a low resource setting. BMC Infectious Diseases 2019;19(1):88.
[PMID: 30683052]
European Standard 2009
European Standard. High eDiciency air filters (EPA, HEPA and
ULPA). European Standard EN 1822-1:2009.
FGDP 2020
Faculty of General Dental Practice (UK). COVID-19: updated
guidance and resources as lockdown eases. fgdp.org.uk/news/
covid-19-updated-guidance-and-resources-lockdown-eases 21
May 2020.
Fors 1986
Fors UG, Berg JO, Sandberg H. Microbiological investigation
of saliva leakage between the rubber dam and tooth during
endodontic treatment. Journal of Endodontics 1986;12(9):396-9.
[PMID: 3463645]
Froum 2020
Froum S, Strange M. COVID-19 and the problem with dental
aerosols. www.perioimplantadvisory.com/periodontics/
oral-medicine-anesthetics-and-oral-systemic-connection/
article/14173521/covid19-and-the-problem-with-dental-
aerosols (accessed 6 June 2020).
GDC 2020
GDC. Aerosol generating procedures. gdc-uk.org/docs/default-
source/covid-19/use-of-aerosol-generating-procedures-
(agps).pdf?sfvrsn=5a95b3b3_2 18 March 2020.
Graetz 2014
Graetz C, Bielfeldt J, Tillner A, Plaumann A, Dörfer CE. Spatter
contamination in dental practices – how can it be prevented?
Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti
din Lasi 2014;118:1122-34. [PMID: 25581979]
Grinshpun 2001
Grinshpun S, Mainelis G, Reponen T, Willeke K, Trunov MA,
Adhikari A. EDect of wearable ionizers on the concentration of
respirable airborne particles and microorganisms. Journal of
Aerosol Science 2001;32(Suppl 1):S335-6.
Gross 1992
Gross KB, Overman PR, Cobb C, Brockmann S. Aerosol
generation by two ultrasonic scalers and one sonic scaler. A
comparative study. Journal of Dental Hygiene 1992;66(7):314-8.
Gurley 1985
Gurley B. Ozone: a pharmaceutical sterilant of the future?
Journal of Parenteral Science and Technology 1985;39(6):256-61.
Górny 2020
Górny RL. Microbial aerosols: sources, properties, health eDects,
exposure assessment – a review. KONA Powder and Particle
Journal 2020;37:64-84. [DOI: 10.14356/kona.2020005]
Harrel 1996
Harrel SK. Clinical use of an aerosol-reduction device with
an ultrasonic scaler. Compendium of Continuing Education in
Dentistry 1996;17(12):1185-93; quiz 1194.
Harrel 2004
Harrel SK, Molinari J. Aerosols and splatter in dentistry:
a brief review of the literature and infection control
implications. Journal of the American Dental Association (1939)
2004;135(4):429-37.
Higgins 2019
Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ,
et al. Cochrane Handbook for Systematic Reviews of
Interventions. 2nd edition. Hoboken (NJ): Wiley-Blackwell,
2019.
Holloman 2015
Holloman JL, Mauriello SM, Pimenta L, Arnold RR. Comparison
of suction device with saliva ejector for aerosol and spatter
reduction during ultrasonic scaling. Journal of the American
Dental Association (1939) 2015;146(1):27-33. [PMID: 25569495]
Ishihama 2008
Ishihama K, Iida S, Koizumi H, Wada T, Adachi T, Isomura-
Tanaka E, et al. High incidence of blood exposure due to
imperceptible contaminated splatters during oral surgery.
Journal of Oral and Maxillofacial Surgery 2008;66(4):704-10.
[PMID: 18355594]
Jacks 2002
Jacks ME. A laboratory comparison of evacuation devices on
aerosol reduction. Journal of Dental Hygiene 2002;76:202-6.
Jain 2020
Jain M, Mathur A, Mathur A, Mukhi PU, Ahire M, Pingal C.
Qualitative and quantitative analysis of bacterial aerosols in
dental clinical settings: risk exposure towards dentist, auxiliary
staD, and patients. Journal of Family Medicine and Primary Care
2020;9(2):1003-8. [PMID: 32318458]
James 2016
James R, Mani A. Dental aerosols: a silent hazard in dentistry!
International Journal of Scientific Research 2016;5:1761-3.
Jawade 2016
Jawade R, Bhandari V, Ugale G, Taru S, Khaparde S, Kulkarni A,
et al. Comparative evaluation of two diDerent ultrasonic liquid
coolants on dental aerosols. Journal of Clinical and Diagnostic
Research : JCDR 2016;10(7):ZC53-7. [PMID: 27630954]
Interventions to reduce contaminated aerosols produced during dental procedures for preventing infectious diseases (Protocol)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
10
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Kormuth 2018
Kormuth KA, Lin K, Prussin AJ II, Vejerano EP, Tiwari AJ, Cox SS,
et al. Influenza virus infectivity is retained in aerosols and
droplets independent of relative humidity. Journal of Infectious
Diseases 2018;218(5):739-47.
Laheij 2012
Laheij AM, Kistler JO, Belibasakis GN, Välimaa H, de Soet JJ.
Healthcare-associated viral and bacterial infections in
dentistry. Journal of Oral Microbiology 2012;4:4. [DOI: 10.3402/
jom.v4i0.17659]
Lefebvre 2019
Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C,
Metzendorf M-I, et al. Technical supplement to Chapter 4:
Searching for and selecting studies. In: Higgins JP, Thomas
J, Chandler J, Cumpston MS, Li T, Page MJ, et al, editor(s).
Cochrane Handbook for Systematic Reviews of Interventions,
Version 6 (updated July 2019). Cochrane, 2019. Available from:
www.training.cochrane.org/handbook.
Lessler 2009
Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE,
Cummings DA. Incubation periods of acute respiratory viral
infections: a systematic review. Lancet Infectious Diseases
2009;9(5):291-300.
Leung 2020
Leung NH, Chu DK, Shiu EY, Chan K-H, McDevitt JJ, Hau
Benien JP, et al. Respiratory virus shedding in exhaled breath
and eDicacy of face masks. Nature Medicine 2020;26:676-80.
[DOI: 10.1038/s41591-020-0843-2]
Lewis 2020
Lewis D. Is the coronavirus airborne? Experts can't agree.
Nature 2020;580(7802):175. [PMID: 32242113]
Lu 2020
Lu M. The front line: visualizing the occupations with
the highest COVID-19 risk. Visual Capitalist 15 April 2020.
[www.visualcapitalist.com/the-front-line-visualizing-the-
occupations-with-the-highest-covid-19-risk/]
McDonnell 2006
McDonnell G. Hydrogen peroxide fogging/fumigation. Journal
of Hospital Infection 2006;62(3):385-6. [PMID: 16337711]
Meng 2020
Meng L, Hua F, Bian Z. Coronavirus disease 2019 (COVID-19):
emerging and future challenges for dental and oral medicine.
Journal of Dental Research 2020;99(5):481-7.
Merriam-Webster 2020
Merriam-Webster Online Medical Dictionary. Saliva ejector.
www.merriam-webster.com/medical/saliva%20ejector
(accessed 5 May 2020).
Monarca 2000
Monarca S, Grottolo M, Renzi D, Paganelli C, Sapelli P, Zerbini I,
et al. Evaluation of environmental bacterial contamination
and procedures to control cross infection in a sample of Italian
dental surgeries. Occupational and Environmental Medicine
2000;57(11):721-6. [PMID: 11024194]
Muzzin 1999
Muzzin KB, King TB, Berry CW. Assessing the clinical
eDectiveness of an aerosol reduction device for the air polisher.
Journal of the American Dental Association 1999;130(9):1354-9.
Narayana 2016
Narayana TV, Mohanty L, Sreenath G, Vidhyadhari P. Role of
preprocedural rinse and high volume evacuator in reducing
bacterial contamination in bioaerosols. Journal of Oral and
Maxillofacial Pathology 2016;20(1):59-65.
NCUDSPH 2020
Le Collège National des Chirurgiens-Dentistes Universitaires en
Santé Publique. Recommendations to deal with the Covid19
epidemic. www.dentairesantepublique.fr/recommandations-
face-a-lepidemie-covid19/ (accessed 18 March 2020).
OSHA 2020
US Department of Labor: Occupational Safety and Health
Administration. Guidance on preparing workplaces for
COVID-19. www.osha.gov/Publications/OSHA3990.pdf
(accessed prior to 16 June 2020).
Pasquarella 2000
Pasquarella C, Pitzurra O, Savino A. The index of microbial air
contamination. Journal of Hospital Infection 2000;46(4):241-56.
Peng 2020
Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes
of 2019-nCoV and controls in dental practice. International
Journal of Oral Science 2020;12(1):1-6.
Polednik 2014
Polednik B. Aerosol and bioaerosol particles in a dental oDice.
Linking Exposure and Health in Environmental Public Health
Tracking 2014;134:405-9.
Qian 2010
Qian H, Li Y, Sun H, Nielsen PV, Huang X, Zheng X. Particle
removal eDiciency of the portable HEPA air cleaner in a
simulated hospital ward. Building Simulation 2010;3(3):215-24.
Rautemaa 2006
Rautemaa R, Nordberg A, Wuolijoki-Saaristo K, Meurman J.
Bacterial aerosols in dental practice – a potential
hospital infection problem? Journal of Hospital Infection
2006;64(1):76-81. [PMID: 16820249]
Rayyan 2016 [Computer program]
Qatar Computing Research Institute, Hamad Bin Khalifa
University Rayyan QCRI, the Systematic Reviews web app. Doha,
Qatar: Qatar Computing Research Institute, Hamad Bin Khalifa
University, 2016.
Review Manager 2014 [Computer program]
Nordic Cochrane Centre, The Cochrane Collaboration Review
Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic
Cochrane Centre, The Cochrane Collaboration, 2014.
Interventions to reduce contaminated aerosols produced during dental procedures for preventing infectious diseases (Protocol)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
11
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Samaranayake 1989
Samaranayake LP, Reid J, Evans D. The eDicacy of rubber dam
isolation in reducing atmospheric bacterial contamination.
ASDC Journal of Dentistry for Children 1989;56(6):442-4. [PMID:
2681303]
Samaranayake 2004
Samaranayake LP, Peiris M. Severe acute respiratory syndrome
and dentistry: a retrospective view. Journal of the American
Dental Association (1939) 2004;135(9):1292-302. [PMID:
15493394]
Sato 1990
Sato H, Wananabe Y, Miyata H. Virucidal eDect of ozone
treatment of laboratory animal viruses. Jikken Dobutsu.
Experimental Animals 1990;39(2):223-9. [PMID: 2163330]
Sawhney 2015
Sawhney A, Venugopal S, Babu GR, Garg A, Mathew M,
Yadav M, et al. Aerosols how dangerous they are in clinical
practice. Journal of Clinical and Diagnostic Research : JCDR
2015;9(4):ZC52-7.
Scannapieco 1999
Scannapieco F. Role of oral bacteria in respiratory infection.
Journal of Periodontology 1999;70:793-801.
Scannapieco 2004
Scannapieco FA, Ho AW, DiTolla M, Chen C, Dentino AR.
Exposure to the dental environment and prevalence of
respiratory illness in dental student populations. Journal
(Canadian Dental Association) 2004;70(3):170-4. [PMID:
15003164]
Sethi 2019
Sethi KS, Mamajiwala A, Mahale S, Raut CP, Karde P.
Comparative evaluation of the chlorhexidine and cinnamon
extract as ultrasonic coolant for reduction of bacterial load in
dental aerosols. Journal of Indian Society of Periodontology
2019;23(3):226-33. [PMID: 31143003]
Sotiriou 2008
Sotiriou M, Ferguson SF, Davey M, Wolfson JM, Demokritou P,
Lawrence J, et al. Measurement of particle concentrations in
a dental oDice. Environmental Monitoring and Assessment
2008;137(1-3):351-61. [DOI: 10.1007/s10661-007-9770-7]
Sterne 2016
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND,
Viswanathan M, et al. ROBINS-I: a tool for assessing risk
of bias in non-randomised studies of interventions. BMJ
2016;355:i4919. [DOI: 10.1136/bmj.i4919]
Stockwell 2019
Stockwell RE, Ballard EL, O'Rourke P, Knibbs LD, Morawska L,
Bell SC. Indoor hospital air and the impact of ventilation on
bioaerosols: a systematic review. Journal of Hospital Infection
2019;103(2):175-84.
Szymańska 2007
Szymańska J. Dental bioaerosol as an occupational hazard in a
dentist's workplace. Annals of Agricultural and Environmental
Medicine : AAEM 2007;14(2):203-7. [PMID: 18247451]
Upendran 2020
Upendran A, Geiger Z. https://www.ncbi.nlm.nih.gov/books/
NBK470356/. January 2020 edition. StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing, Updated 2020 Feb
17.
Veeck 2004
Veeck AC. Types of HEPA filters. In: NAFA Guide to Air Filtration.
3 edition. Middleton (WI): NAFA, 2004.
Veena 2015
Veena HR, Mahantesha S, Joseph Preethi A, Patil Sudhir R,
Patil Suvarna H. Dissemination of aerosol and splatter during
ultrasonic scaling: a pilot study. Journal of Infection and Public
Health 2015;8(3):260-5.
Verbeek 2020
Verbeek JH, Rajamaki B, Ijaz S, Sauni R, Toomey E,
Blackwood B, et al. Personal protective equipment for
preventing highly infectious diseases due to exposure to
contaminated body fluids in healthcare staD. Cochrane
Database of Systematic Reviews 2020, Issue 4. Art. No:
CD011621. [DOI: 10.1002/14651858.CD011621.pub4]
Warnakulasuriya 2020
Warnakulasuriya S. Protecting dental manpower from COVID-19
infection. Oral Diseases 2020 May 13 [Epub ahead of print]. [DOI:
10.1111/odi.13410]
Watanabe 2018
Watanabe A, Tamaki N, Yokota K, Matsuyama M, Kokeguchi S.
Use of ATP bioluminescence to survey the spread of aerosol and
splatter during dental treatments. Journal of Hospital Infection
2018;99(3):303-5. [PMID: 29551649]
WHO 2020
World Health Organization. WHO timeline – COVID-19.
www.who.int/news-room/detail/27-04-2020-who-timeline---
covid-19 (accessed prior to 16 June 2020).
WHO 2020a
World Health Organization. Maintaining essential health
services:operational guidance for theCOVID-19 context - Interim
guide. WHO/2019-nCoV/essential_health_services/2020.2 1
June 2020:34 and 36.
Yadav 2015
Yadav N, Agrawal B, Maheshwari C. Role of high-eDiciency
particulate arrestor filters in control of air borne infections
in dental clinics. SRM Journal of Research in Dental Sciences
2015;6(4):240-2.
Zemouri 2017
Zemouri C, de Soet H, Crielaard W, Laheij A. A scoping review
on bio-aerosols in healthcare and the dental environment. PloS
One 2017;12(5):e0178007.
Interventions to reduce contaminated aerosols produced during dental procedures for preventing infectious diseases (Protocol)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
12
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Zyris 2020
Zyris: dental isolation systems and mouthpieces (formerly
Isolite). www.zyris.com/ 2020.
 
A P P E N D I C E S
Appendix 1. MEDLINE Ovid search strategy
1. exp dentistry/
2. exp dental facilities/
3. infection control, dental/
4. exp dentists/
5. dental staD/
6. exp dental auxiliaries/
7. (dental or dentist$ or hygienist$).mp.
8. ((oral or maxillofacial) adj5 (care$ or procedure$ or surgery or surgical or medicine)).mp.
9. orthodonti$.mp.
10. periodont$.mp.
11. (tooth or teeth or gum$ or endodont$ or plaque$ or pulpotom$ or pulpectom$ or "cavity prep$" or molar$ or bicuspid$ or premolar$
or pre-molar$ or incisor$ or canine$ or eyetooth or eyeteeth or cuspid$).mp.
12. ((scal$ adj2 polish$) or "root canal" or (root adj6 resect$) or (root$ adj3 planing) or apicectom$ or apicoectom$).mp.
13. ((root$ or periodont$ or dental or subgingiv$ or gingiv$ or supragingiv$) adj5 (scale or scaling or scaler$ or curettage)).mp.
14. Dental high speed equipment/
15. ("high speed air rotor$" or "low speed handpiece$" or "low speed hand piece$" or micromotor$ or "turbine handpiece$" or
"electrosurgery unit" or "air polisher$" or "prophy angle$" or "air-water syringe$" or "high speed hand piece$" or "high speed handpiece
$" or "three-way air syringe$" or "threeway air syringe$" or "ultrasonic scaler$" or "hard-tissue laser$" or "dental drill$" or "piezo unit$"
or "piezo hand piece$" or "piezo handpiece$" or "rotary instrument$" or "air abrasion" or "water spray$").mp.
16. or/1-15
17. Air microbiology/
18. Air pollution, indoor/
19. Aerosols/
20. Inhalation exposure/
21. (aerosol$ or bioaerosol$).mp.
22. (droplet$ or splatter$ or spatter$ or microbe$ or bacillus or germ$ or microorganism$ or virus$ or viral or coronavirus$ or COVID$ or
"middle east? respiratory syndrome$" or MERS or MERS-CoV or "camel flu" or SARS or "sudden acute respiratory syndrome$" or "Wuhan
virus$" or 2019-nCoV or SARS-CoV-2 or SARS-CoV or SARS-CoV-1 or SARS-1).mp.
23. (air adj5 (pollut$ or quality or impur$)).mp.
24. or/17-23
25. Decontamination/
26. ("high volume evacuat$" or HVE or "high volume aspirat$").mp.
27. Rubber dams/
28. ((rubber adj dam$) or (oral adj dam$) or (dental adj dam$) or (latex adj dam$) or KoDerdam).mp.
29. ("Optra Dam" or "OptraDam Plus" or OptiDam or FlexiDam or "Hygenic Fiesta").mp.
30. Suction/
31. ("saliva ejector" or "low volume aspirat$" or (suction adj2 saliva)).mp.
32. Air filters/
33. (air adj5 (filter$ or filtration or purif$ or clean$)).mp.
34. ((HEPA or "High EDiciency Particulate Air" or "High EDiciency Particulate Arrestance") adj5 filter$).mp.
35. Air ionization/
36. (ionis$ or ioniz$).mp.
37. Ozone/
38. (ozonis$ or ozoniz$).mp.
39. Ultraviolet rays/
40. (ultraviolet or UV or ultra-violet or actinic).mp.
41. ((aerosol$ or bioaerosol$ or droplet$ or spatter or splatter) adj2 reduc$).mp.
42. Fumigation/
43. (fog$ or fumigat$ or decontaminat$ or "smoke out" or smokeout or depollut$ or depurat$).mp.
44. or/25-43
45. 16 and 24 and 44
This subject search will be linked to the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials in MEDLINE:
sensitivity-maximising version (2008 revision) (Lefebvre 2019).
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1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. placebo.ab.
5. drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9. or/1-8
10. exp animals/ not humans.sh.
11. 9 not 10
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